Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00083421
Status:
COMPLETED
Last Update Posted:
2012-06-13
First Post:
2004-05-24
Brief Title:
Effects of ONO-2506PO in Patients With Alzheimers Disease
Sponsor:
Ono Pharma USA Inc
Organization:
Ono Pharmaceutical Co Ltd
Study Overview
Official Title:
Effects of ONO-2506PO in Patients With Alzheimers Disease
Status:
COMPLETED
Status Verified Date:
2012-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to establish the presence of an effect of treatment with ONO-2506PO in patients with Alzheimers Disease based upon cognitive and global scales
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None